- Home
- SLDB
as of 01-23-2026 3:57pm EST
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | CHARLESTOWN |
| Market Cap: | 444.9M | IPO Year: | 2018 |
| Target Price: | $14.70 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.41 - $7.37 | Next Earning Date: | 03-05-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered SLDB Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Solid Biosciences Inc. (SLDB)
Director
Avg Cost/Share
$5.43
Shares
1,053
Total Value
$5,717.79
Owned After
17,278
SEC Form 4
Chief Regulatory Officer
Avg Cost/Share
$5.11
Shares
4,483
Total Value
$22,908.13
Owned After
26,660
SEC Form 4
Chief Operating Officer
Avg Cost/Share
$5.11
Shares
4,932
Total Value
$25,202.52
Owned After
32,908
SEC Form 4
Chief Technology Officer
Avg Cost/Share
$5.11
Shares
2,701
Total Value
$13,802.11
Owned After
26,622
SEC Form 4
President and CEO
Avg Cost/Share
$5.11
Shares
10,808
Total Value
$55,228.88
Owned After
81,388
SEC Form 4
Director
Avg Cost/Share
$4.12
Shares
3,278
Total Value
$13,505.36
Owned After
17,278
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Tan Kevin | SLDB | CFO & Treasurer | Jan 13, 2026 | Sell | $5.27 | 5,704 | $30,060.08 | 46,100 | |
| Ganot Ilan | SLDB | Director | Jan 5, 2026 | Sell | $5.43 | 1,053 | $5,717.79 | 17,278 | |
| Hanrahan Jessie | SLDB | Chief Regulatory Officer | Dec 3, 2025 | Sell | $5.11 | 4,483 | $22,908.13 | 26,660 | |
| Howton David T | SLDB | Chief Operating Officer | Dec 3, 2025 | Sell | $5.11 | 4,932 | $25,202.52 | 32,908 | |
| Herzich Paul | SLDB | Chief Technology Officer | Dec 3, 2025 | Sell | $5.11 | 2,701 | $13,802.11 | 26,622 | |
| Cumbo Alexander | SLDB | President and CEO | Dec 3, 2025 | Sell | $5.11 | 10,808 | $55,228.88 | 81,388 | |
| Ganot Ilan | SLDB | Director | Nov 10, 2025 | Sell | $4.12 | 3,278 | $13,505.36 | 17,278 |
Compare SLDB vs Leading Stocks
See how SLDB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLDB Solid Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.